Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining -2.16% today. In the last week its performance is -2.69%, and 9.75% for the past quarter. Currently, Allergan plc, AGN has a target price of 299.06, so today’s gain of -2.16% is a significant step towards its target price. The GAP today is therefore -0.71%.
Allergan plc (NYSE:AGN), has a market cap of 94505.34, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 87.50%.
At the current price of 238.68, it has a dividend yield of *TBA, and its target price is 299.06. This is with a profit margin of 27.00%, and total debt/equity of 0.56. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 13.99.
With a current EPS of -6.14, and a forecasted EPS growth for next year at 21.82%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 13.49%.
Performance for the year is -14.46%. Since its IPO date on 2/17/1993, the total performance to date is -23.62%.
Volume today for Allergan plc (NYSE:AGN), is 2426700, while its average volume is 3039.97. Whilst the total gain today was -2.16%, it did have a day high of -8.65%.
Volatility for this week has been at 2.14%, and 2.01% for the month. The 52-week low for Allergan plc, AGN has been 22.09%, while the 52-week-high has reached -26.03%.
Looking at its return of investments, which is -1.30%, and its return on assets is 3.00%. Allergan plc (NYSE:AGN) has an operating margin of -16.50%. With a sales growth of 1.50% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.52, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 6.15, along with a P/B of 1.32. Meanwhile it has a p/cash of 186.55.